Cns Drugs impact factor, indexing, ranking (2024)


cns

Aim and Scope

The Cns Drugs is a research journal that publishes research related to Medicine. This journal is published by the Adis International Ltd. The ISSN of this journal is 11791934, 11727047. Based on the Scopus data, the SCImago Journal Rank (SJR) of cns drugs is 1.485.

Also, please check the following important details about cns drugs: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Cns Drugs Ranking

Impact Factor: 6.497
Total Citations: 6627
SJR (SCImago Journal Rank): 1.485
Quartile: Q1

The Impact Factor of Cns Drugs is 6.497.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: CNS Drugs
Publisher: Adis International Ltd
ISSN: 11791934, 11727047
Type: journal
Journal Scope: Medicine
Country: United Kingdom
H-Index: 122
SJR: 1.485
Quartile: Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)

cns drugs Indexing

The cns drugs is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Cns Drugs Impact Factor 2024

The latest impact factor of cns drugs is 6.497.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Cns Drugs Quartile

The latest Quartile of cns drugs is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Cns Drugs?

If your research is related to Medicine, then visit the official website of cns drugs and send your manuscript.

Tips for publishing in Cns Drugs:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of cns drugs is 6.497.
  • The cns drugs is a reputed research journal.
  • It is published by Adis International Ltd.
  • The journal is indexed in UGC CARE, Scopus, SCIE, PubMed.
  • The (SJR) SCImago Journal Rank is 1.485.

Sources: cns drugs







SIMILIAR JOURNALS


DENTAL AND MEDICAL PROBLEMS

ISSN: 1644-387X
Publisher: WROCLAW MEDICAL UNIV

RESUSCITATION PLUS

ISSN: 2666-5204
Publisher: ELSEVIER

WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE

ISSN: 2311-8571
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

AMERICAN JOURNAL OF CHINESE MEDICINE

ISSN: 0192-415X
Publisher: WORLD SCIENTIFIC PUBL CO PTE LTD

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

ISSN: 1350-6129
Publisher: TAYLOR & FRANCIS LTD

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

ISSN: 1084-9785
Publisher: MARY ANN LIEBERT, INC

CURRENT MEDICAL RESEARCH AND OPINION

ISSN: 0300-7995
Publisher: TAYLOR & FRANCIS LTD

DENTOMAXILLOFACIAL RADIOLOGY

ISSN: 0250-832X
Publisher: BRITISH INST RADIOLOGY

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

ISSN: 0014-2972
Publisher: WILEY

INDIAN JOURNAL OF MEDICAL RESEARCH

ISSN: 0971-5916
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.